104 related articles for article (PubMed ID: 38815786)
1. Losartan and metabolite EXP3179 activate endothelial function without lowering blood pressure in AT2 receptor KO mice.
Sauge E; White Z; Lizotte F; Yuen C; Atmuri NDP; Ciufolini MA; Geraldes P; Bernatchez P
Eur J Pharmacol; 2024 May; 977():176663. PubMed ID: 38815786
[TBL] [Abstract][Full Text] [Related]
2. Losartan metabolite EXP3179 is a unique blood pressure-lowering AT1R antagonist with direct, rapid endothelium-dependent vasoactive properties.
Sauge E; Pechkovsky D; Atmuri NDP; Tehrani AY; White Z; Dong Y; Cait J; Hughes M; Tam A; Donen G; Yuen C; Walker MJA; McNagny KM; Sin DD; Ciufolini MA; Bernatchez P
Vascul Pharmacol; 2022 Dec; 147():107112. PubMed ID: 36179789
[TBL] [Abstract][Full Text] [Related]
3. Losartan metabolite EXP3179 activates Akt and endothelial nitric oxide synthase via vascular endothelial growth factor receptor-2 in endothelial cells: angiotensin II type 1 receptor-independent effects of EXP3179.
Watanabe T; Suzuki J; Yamawaki H; Sharma VK; Sheu SS; Berk BC
Circulation; 2005 Sep; 112(12):1798-805. PubMed ID: 16172287
[TBL] [Abstract][Full Text] [Related]
4. Role of the angiotensin II AT2-subtype receptors in the blood pressure-lowering effect of losartan in salt-restricted rats.
Gigante B; Piras O; De Paolis P; Porcellini A; Natale A; Volpe M
J Hypertens; 1998 Dec; 16(12 Pt 2):2039-43. PubMed ID: 9886894
[TBL] [Abstract][Full Text] [Related]
5. Regulation of peroxisome proliferator-activated receptor gamma activity by losartan metabolites.
Schupp M; Lee LD; Frost N; Umbreen S; Schmidt B; Unger T; Kintscher U
Hypertension; 2006 Mar; 47(3):586-9. PubMed ID: 16365190
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II stimulates canonical TGF-β signaling pathway through angiotensin type 1 receptor to induce granulation tissue contraction.
Ehanire T; Ren L; Bond J; Medina M; Li G; Bashirov L; Chen L; Kokosis G; Ibrahim M; Selim A; Blobe GC; Levinson H
J Mol Med (Berl); 2015 Mar; 93(3):289-302. PubMed ID: 25345602
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Marfan Syndrome Aortic Root Dilation by Losartan: Role of Angiotensin II Receptor Type 1-Independent Activation of Endothelial Function.
Sellers SL; Milad N; Chan R; Mielnik M; Jermilova U; Huang PL; de Crom R; Hirota JA; Hogg JC; Sandor GG; Van Breemen C; Esfandiarei M; Seidman MA; Bernatchez P
Am J Pathol; 2018 Mar; 188(3):574-585. PubMed ID: 29433732
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis.
Naito T; Ma LJ; Yang H; Zuo Y; Tang Y; Han JY; Kon V; Fogo AB
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F683-91. PubMed ID: 20042458
[TBL] [Abstract][Full Text] [Related]
9. Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR.
Touyz RM; Endemann D; He G; Li JS; Schiffrin EL
Hypertension; 1999 Jan; 33(1 Pt 2):366-72. PubMed ID: 9931131
[TBL] [Abstract][Full Text] [Related]
10. EXP3179 inhibits collagen-dependent platelet activation via glycoprotein receptor-VI independent of AT1-receptor antagonism: potential impact on atherothrombosis.
Grothusen C; Umbreen S; Konrad I; Stellos K; Schulz C; Schmidt B; Kremmer E; Teebken O; Massberg S; Luchtefeld M; Schieffer B; Gawaz M
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1184-90. PubMed ID: 17347483
[TBL] [Abstract][Full Text] [Related]
11. AT1 and AT2 receptors in human glomerular endothelial cells at different passages.
Cresci B; Giannini S; Pala L; Mavilia C; Manuelli C; Cappugi P; Maggi E; Rotella CM
Microvasc Res; 2003 Jul; 66(1):22-9. PubMed ID: 12826071
[TBL] [Abstract][Full Text] [Related]
12. Functions of AT1 and AT2 angiotensin receptors in the paraventricular nucleus of the rat, correlating single-unit and cardiovascular responses.
Khanmoradi M; Nasimi A
Brain Res Bull; 2017 Jun; 132():170-179. PubMed ID: 28596051
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II receptor-independent antiinflammatory and antiaggregatory properties of losartan: role of the active metabolite EXP3179.
Krämer C; Sunkomat J; Witte J; Luchtefeld M; Walden M; Schmidt B; Tsikas D; Böger RH; Forssmann WG; Drexler H; Schieffer B
Circ Res; 2002 Apr; 90(7):770-6. PubMed ID: 11964369
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II receptor subtypes AT1 and AT2 are down-regulated by angiotensin II through AT1 receptor by different mechanisms.
Ouali R; Berthelon MC; Bégeot M; Saez JM
Endocrinology; 1997 Feb; 138(2):725-33. PubMed ID: 9003008
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II receptors.
Ardaillou R
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S30-9. PubMed ID: 9892138
[TBL] [Abstract][Full Text] [Related]
16. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.
Stoll M; Steckelings UM; Paul M; Bottari SP; Metzger R; Unger T
J Clin Invest; 1995 Feb; 95(2):651-7. PubMed ID: 7860748
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure-independent inhibition of Marfan aortic root widening by the angiotensin II receptor blocker valsartan.
Tehrani AY; White Z; Milad N; Esfandiarei M; Seidman MA; Bernatchez P
Physiol Rep; 2021 May; 9(10):e14877. PubMed ID: 34042309
[TBL] [Abstract][Full Text] [Related]
18. AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism.
Gohlke P; Pees C; Unger T
Hypertension; 1998 Jan; 31(1 Pt 2):349-55. PubMed ID: 9453327
[TBL] [Abstract][Full Text] [Related]
19. Increased endothelial nitric oxide production after low level lead exposure in rats involves activation of angiotensin II receptors and PI3K/Akt pathway.
Fiorim J; Simões MR; de Azevedo BF; Ribeiro RF; Dos Santos L; Padilha AS; Vassallo DV
Toxicology; 2020 Oct; 443():152557. PubMed ID: 32791093
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II- and IV-induced changes in cerebral blood flow. Roles of AT1, AT2, and AT4 receptor subtypes.
Kramár EA; Harding JW; Wright JW
Regul Pept; 1997 Jan; 68(2):131-8. PubMed ID: 9110385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
